Arvinas Inc (OQ:ARVN)

Business Focus: Pharmaceuticals

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Pfizer (N:PFE)
Odonate Therapeutics (OQ:ODT)
Latest 10 SEC filings (by transaction date) for ARVN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,058  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,212  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,980  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,250 $16.00
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -60 $28.03
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -1,108 $27.04
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -10,777 $26.13
Jul 31/19 Jul 29/19 Peck Ronald Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 72,184  
Jul 31/19 Jul 29/19 Peck Ronald Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 16,041  
Jul 26/19 Jul 24/19 Norwalk Leslie V Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 25,846  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ARVN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,058  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,212  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,980  
Aug 9/19 Aug 7/19 Cassidy Sean A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,250 $16.00
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -60 $28.03
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -1,108 $27.04
Jul 31/19 Jul 29/19 Cassidy Sean A Direct Ownership Common Stock S - Open market or private sale -10,777 $26.13
Jul 31/19 Jul 29/19 Peck Ronald Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 72,184  
Jul 31/19 Jul 29/19 Peck Ronald Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 16,041  
Jul 26/19 Jul 24/19 Norwalk Leslie V Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 25,846  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ARVN

StockTwits